Mawi launches a patch to track your heart health faster and in real time – TechCrunch

If you’ve ever had the misfortune of needing continuous ECG monitoring, you’ve probably used a Holter monitor. It’s like wearing a metal 1980s walkman with a bunch of wires running from it to your chest. If that sounds uncomfortable, and like you don’t sleep or enjoy showers much for the two weeks you need to carry it around, you’ve come across the perfect use case for the Mawi Heart Patch. The company has just launched its product, a two-lead heart monitor that can be read in real time.

There are consumer products that can perform ECG readings, including the Withings ScanWatch (and its fancier sibling, the ScanWatch Horizon), and there are other patches on the market, such as the Zio patch, but Mawi claims to have done something unique, and suggests that its Heart Patch is the very first single-use dual-lead heart monitor ever to hit the market.

The company describes it as “an out-of-the-box wireless solution” and further suggests that the disposable nature of the device is a plus; this means that cardiologists can perform tests on as many patients as needed without having to wait for reusable Holter monitors to return from other patients and to be disinfected and maintained between uses.

“Holter monitors aren’t great,” Mawi CEO Andrew Klymenko curtly states in an interview we did last week, and explains that existing solutions tend to dislodge, peel off, and cause reactions. allergic, thus limiting the monitoring time. As a result, Mawi claims that more than 50% of arrhythmias go undetected. Equally bad: patients have to wait up to a month to receive the results.

Mawi Heart Patch, the company claims, can be applied in less than a minute and you can live as normal while wearing it.

“Patients can shower, sleep, work out,” Klymenko says, and points out that it’s possible to wear the patch and live all aspects of life normally. “Sex is an important and important part of life, and patients can have normal sex when wearing the Mawi patch.”

“Cardiovascular disease poses the greatest risk to our long-term health and is the leading cause of death worldwide. With lack or ineffective oversight that often turns out to be critical, many of these deaths can be prevented with the right preventative measures,” Klymenko said. “Too often, sufferers don’t realize the severity of their symptoms until it’s too late. Many patients who use the Mawi Heart Patch look healthy, exercise daily and show no signs of illness, but suffer from life-threatening heart disease. We’re on a mission to prevent the “silent killers” of the heart, and we’re already working with like-minded clinics that are seeing amazing results. »

The patch connects to a smartphone in the doctor’s office. This device routes data to the cloud, where an AI analyzes the results and highlights anything unusual for cardiologists to take a closer look at. The process is indeed very fast, which means that patients can have feedback and next steps for their treatment.

“In less than 24 hours [the doctors] having a very detailed, accurate and actionable report,” says Klymenko, suggesting that doctors can focus on treatment, rather than having to spend a lot of time analyzing the data. “It only takes two seconds to manage.”

The company currently has around thirty employees, mainly concentrated in Europe. Klymenko himself is from Ukraine and his team is spread all over the world, including teams in Thailand and the United States. To date, the business has been launched.

Mawi won’t share exactly how many devices it has in the field, but Klymenko admits they ship “thousands of devices” every month, to customers across the US, EU and Middle East. -East.

The devices must be prescribed by a doctor, and prices are highly dependent on the medical insurance and healthcare system you’re working on, but Klymenko says the devices typically cost “less than $250 per study.”


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button